Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
53,915.91
52,771.78
48,601.70
49,061.15
46,249.31
56,288.53
59,924.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
53,915.91
52,771.78
48,601.70
49,061.15
46,249.31
56,288.53
59,924.07
Raw Material Cost
44,570.35
43,495.30
42,398.07
40,522.65
40,976.81
50,865.12
52,137.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.71
49.89
70.13
102.06
145.52
185.22
180.88
Selling and Distribution Expenses
4,117.60
3,791.88
3,902.55
4,039.78
3,780.93
4,265.77
4,381.71
Other Expenses
133.33
137.90
110.12
112.34
93.92
143.41
138.67
Total Expenditure (Excl Depreciation)
50,033.99
48,716.11
47,471.93
45,787.88
45,842.44
56,750.25
58,087.00
Operating Profit (PBDIT) excl Other Income
3881.9
4055.7
1129.8
3273.2999999999997
406.9
-461.70000000000005
1837.1000000000001
Other Income
397.36
273.93
7.47
554.05
175.94
-446.33
-95.57
Operating Profit (PBDIT)
7,739.95
8,001.40
4,825.81
7,238.93
3,324.41
3,002.68
5,290.18
Interest
12.71
49.89
70.13
102.06
145.52
185.22
180.88
Exceptional Items
-471.14
-2,144.90
-50.94
9.12
89.75
-2,100.74
-177.93
Gross Profit (PBDT)
9,345.55
9,276.48
6,203.63
8,538.50
5,272.50
5,423.41
7,786.41
Depreciation
3,320.35
3,363.36
3,691.29
3,664.24
3,822.87
4,000.51
3,747.79
Profit Before Tax
3,935.75
2,443.25
1,013.44
3,481.75
-554.24
-3,283.79
1,183.58
Tax
983.19
669.34
225.44
646.58
759.74
278.51
254.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,948.11
1,773.90
788.00
2,835.17
-1,313.97
-3,562.30
935.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,948.11
1,773.90
788.00
2,835.17
-1,313.97
-3,562.30
935.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.45
0.00
0.00
0.00
0.00
0.00
-5.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,952.56
1,773.90
788.00
2,835.17
-1,313.97
-3,562.30
929.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
26,637.88
24,664.78
20,545.79
18,697.47
16,019.24
15,636.74
19,262.96
Earnings per share (EPS)
141.53
85.16
37.83
136.11
-63.08
-171.01
44.89
Diluted Earnings per share
141.53
85.16
37.83
136.11
-63.08
-171.01
44.89
Operating Profit Margin (Excl OI)
7.46%
8.27%
2.32%
6.16%
-1.46%
-0.98%
2.73%
Gross Profit Margin
13.46%
11.0%
9.68%
14.57%
7.07%
1.27%
8.23%
PAT Margin
5.47%
3.36%
1.62%
5.78%
-2.84%
-6.33%
1.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.17% vs 8.58% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 66.45% vs 125.11% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -4.98% vs 60.38% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -74.55% vs -28.82% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Univance Corp. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
53,915.91
51,446.48
2,469.43
4.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
53,915.91
51,446.48
2,469.43
4.80%
Raw Material Cost
44,570.35
44,823.69
-253.34
-0.57%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.71
228.75
-216.04
-94.44%
Selling and Distribution Expenses
4,117.60
4,548.44
-430.84
-9.47%
Other Expenses
133.33
33.79
99.54
294.58%
Total Expenditure (Excl Depreciation)
50,033.99
49,938.84
95.15
0.19%
Operating Profit (PBDIT) excl Other Income
3,881.92
1,507.64
2,374.28
157.48%
Other Income
397.36
602.11
-204.75
-34.01%
Operating Profit (PBDIT)
7,739.95
6,337.59
1,402.36
22.13%
Interest
12.71
228.75
-216.04
-94.44%
Exceptional Items
-471.14
345.67
-816.81
-236.30%
Gross Profit (PBDT)
9,345.55
6,622.79
2,722.76
41.11%
Depreciation
3,320.35
4,227.84
-907.49
-21.46%
Profit Before Tax
3,935.75
2,226.67
1,709.08
76.75%
Tax
983.19
978.86
4.33
0.44%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,948.11
630.21
2,317.90
367.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,948.11
630.21
2,317.90
367.80%
Share in Profit of Associates
0
0
0.00
Minority Interest
4.45
617.61
-613.16
-99.28%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,952.56
1,247.81
1,704.75
136.62%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
26,637.88
29,028.92
-2,391.04
-8.24%
Earnings per share (EPS)
141.53
21.91
119.62
545.96%
Diluted Earnings per share
141.53
21.91
119.62
545.96%
Operating Profit Margin (Excl OI)
7.46%
2.93%
0.00
4.53%
Gross Profit Margin
13.46%
12.55%
0.00
0.91%
PAT Margin
5.47%
1.22%
0.00
4.25%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,391.59 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 2.17% vs 8.58% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 295.26 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 66.45% vs 125.11% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 734.26 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -4.98% vs 60.38% in Mar 2024
Annual - Interest
Interest 1.27 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -74.55% vs -28.82% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.46%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






